Aprazer Healthcare Private Limited is engaged in strategic marketing of Life Saving drugs for diseases such as Hepatitis B, Hepatitis C & HIV/AIDS.Core Values of the company is to make affordable Healthcare for all without compromising on the quality of the drugs by choosing the Certified & Reputed manufacturers and delivering a product with Maximum quality accessible to all sections of the society. Aprazer is aiming to produce high customer equity. Aprazer successfully and efficiently blending skilled people, resources, organizational structure and decisions for implementing strategies at all levels.
Aprazer Healthcare Private Limited is the part of the healthcare sector that deals with medications. The industry comprises different subfields pertaining to the marketing of medications. These more or less interdependent subfields consist of drug manufacturers, drug marketers, and biotechnology companies.
The main goal of the Aprazer Healthcare is to provide drugs that prevent infections, maintain health, and cure diseases. This industry directly affects the global population, so a number of international regulatory bodies monitor things like drug safety, patents, quality, and pricing. Here are some of those regulatory entities:
World Health Organization (or WHO)
US Food and Drug Administration (or FDA)
Medicines and Healthcare Products Regulatory Agency (or MHRA)
The Founder directors of Aprazer Healthcare have made a great deal of progress over the last decade due to a research-oriented approach that has improved technologies, developed infrastructures, and increased research in the field of Marketing & Distribution of Pharmaceuticals. Thanks to biotechnology, various formulations have been developed to cure or stop the growth of several major infections, including HIV and certain types of cancer.
The global pharmaceutical industry was worth an estimated $1 trillion in 2014. In 2013, global pharmaceutical markets generated revenues of $980.1 billion. That year, North America (the US and Canada) contributed 41% of sales, while Europe contributed 27.4%.